These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 7042002)
1. Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. Castro-Malaspina H; Gay RE; Jhanwar SC; Hamilton JA; Chiarieri DR; Meyers PA; Gay S; Moore MA Blood; 1982 May; 59(5):1046-54. PubMed ID: 7042002 [TBL] [Abstract][Full Text] [Related]
3. Stromal cell progeny of murine bone marrow fibroblast colony-forming units are clonal endothelial-like cells that express collagen IV and laminin. Perkins S; Fleischman RA Blood; 1990 Feb; 75(3):620-5. PubMed ID: 2404524 [TBL] [Abstract][Full Text] [Related]
4. Human bone marrow fibroblast colony-forming units (CFU-F). Castro-Malaspina H; Ebell W; Wang S Prog Clin Biol Res; 1984; 154():209-36. PubMed ID: 6382294 [TBL] [Abstract][Full Text] [Related]
5. Granulopoietic effects of human bone marrow fibroblastic cells and abnormalities in the "granulopoietic microenvironment". Greenberg BR; Wilson FZ; Woo L Blood; 1981 Sep; 58(3):557-64. PubMed ID: 6942847 [TBL] [Abstract][Full Text] [Related]
6. [Clonogenic cultivation of bone marrow fibroblast precursors in human myeloproliferative diseases]. Kolosova LIu; Vladimirskaia EB; Kovaleva LG Eksp Onkol; 1988; 10(2):46-8. PubMed ID: 3292215 [TBL] [Abstract][Full Text] [Related]
7. Granulocytic and stromal progenitors in the bone marrow of patients with primary myelofibrosis. Hotta T; Utsumi M; Katoh T; Maeda H; Yamao H; Yamada H Scand J Haematol; 1985 Mar; 34(3):251-5. PubMed ID: 3992191 [TBL] [Abstract][Full Text] [Related]
8. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM; Gulati SC Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [TBL] [Abstract][Full Text] [Related]
9. Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases. Grossi A; Vannucchi AM; Rafanelli D; Vannucchi L; Ferrini PR Am J Hematol; 1987 Aug; 25(4):371-6. PubMed ID: 3497577 [TBL] [Abstract][Full Text] [Related]
10. Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders. Jordan JH; Jäger E; Sperr WR; Schwarzinger I; Födinger M; Fritsche-Polanz R; Ohler L; Geissler K; Valent P Eur J Clin Invest; 2003 Jul; 33(7):611-8. PubMed ID: 12814399 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of in vitro growth pattern of megakaryocyte progenitors (CFU-M) in myeloproliferative disorders. Hamaguchi H; Takano N; Sakamaki H; Enokihara H; Saito K; Furusawa S; Shishido H Eur J Haematol; 1988 Aug; 41(2):163-9. PubMed ID: 3410010 [TBL] [Abstract][Full Text] [Related]
12. Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism. Jensen MK; Riisbro R; Holten-Andersen MN; Brown Pde N; Junker P; Brünner N; Hasselbalch HC Eur J Haematol; 2003 Oct; 71(4):276-82. PubMed ID: 12950237 [TBL] [Abstract][Full Text] [Related]
13. Dual role of fibronectin in hematopoietic differentiation. Weinstein R; Riordan MA; Wenc K; Kreczko S; Zhou M; Dainiak N Blood; 1989 Jan; 73(1):111-6. PubMed ID: 2910353 [TBL] [Abstract][Full Text] [Related]
14. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic evidence for a clonal disorder involving CFU-GEMM, BFU-E and CFU-C in patients with myeloproliferative disorders. Sugiyama H; Ichiba S; Okuno Y; Takahashi T; Imura H; Nakamura K; Iho S; Hoshino T; Okada T; Furukawa H Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1022-32. PubMed ID: 2588952 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF. Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786 [TBL] [Abstract][Full Text] [Related]
17. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro. Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617 [TBL] [Abstract][Full Text] [Related]